Your browser doesn't support javascript.
loading
Discovery of dual PARP and CDK6 inhibitors for triple-negative breast cancer with wild-type BRCA.
Wang, Cheng; Luo, Heng; Chen, Xinye; Zhang, Yonglei; Lu, Dehua; Liu, Xingchen; Yin, Fucheng; Li, Shang; Kong, Lingyi; Wang, Xiaobing.
Afiliación
  • Wang C; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China; Clinical Pharmacology Institute, School of Pharmacy, Nanchang University, N
  • Luo H; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Chen X; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Zhang Y; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Lu D; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Liu X; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Yin F; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Li S; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Kong L; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China. Electronic address: cpu_lykong@126.com.
  • Wang X; Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China. Electronic address: xbwang@cpu.edu.cn.
Bioorg Chem ; 139: 106683, 2023 10.
Article en En | MEDLINE | ID: mdl-37379778

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Humans Idioma: En Revista: Bioorg Chem Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Humans Idioma: En Revista: Bioorg Chem Año: 2023 Tipo del documento: Article